{
  "drug_name": "Clarithromycin",
  "tradename": "Biaxin, Biaxin XL",
  "usage_and_dosing": {
    "general": [
      "Clarithromycin is a macrolide antibiotic used as alternative therapy for a variety of respiratory tract and skin infections, in combination for some mycobacterial infections and in combination regimens to eradicate H. pylori infections.",
      "Mechanisms of Clarithromycin resistance: methylation of ribosomal target (high level resistance) and efflux pump (low level resistance).",
      "Rates of susceptibility to Clarithromycin of Streptococcus pyogenes and Streptococcus pneumoniae are highly variable by geographic location.",
      "Caution: numerous drug interactions (see chart below, not all-inclusive)",
      "See Macrolides, Overview for discussion of class-wide adverse effects, including QTc interval prolongation."
    ],
    "adult_dose": {
      "aecb_or_cap_dose": "500 mg (standard) po q12h x 7-14 days or 500 mg (extended release) 2 tabs po once daily",
      "pertussis_dose": "500 mg po bid x 7 days",
      "tonsillopharyngitis_dose": "250 mg po q12h x 10 days",
      "skin_structure_infections_dose": "250 mg po q12h x 10 days"
    },
    "pediatric_dose": {
      "dose_age_gt_28_days": "15 mg/kg/day (divided q12h)",
      "max_day": "1 gm"
    }
  },
  "renal_adjustment": {
    "note": "recommendations are for the immediate-release formulations only.",
    "half_life_normal": "5-7",
    "half_life_esrd": "22",
    "dose_renal_function_normal": "500 mg po q12h",
    "crcl_or_egfr": "CrCl >50: No dosage adjustment. CrCl 10-50: 500 mg q12-24h. CrCl <10: 500 mg q24h",
    "hemodialysis": "500 mg q24h (dose AD on dialysis days)",
    "capd": "500 mg q24h",
    "crrt": "500 mg q12-24h",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "mild_impairment_child_pugh_a": "No dosage adjustment",
    "moderate_impairment_child_pugh_b": "No dosage adjustment",
    "severe_impairment_child_pugh_c": "No dosage adjustment"
  },
  "adverse_effects": [
    "Treatment stopped due to adverse effects (3%), neutropenia (1%), thrombocytopenia (rare), increased PT/PTT (1%), nausea/vomiting (3%)--less GI upset with extended release formulation, diarrhea (3-6%), C. difficile colitis, increased LFTs (rare), increased BUN/Creatinine (4%), headache (2%).",
    "Clarithromycin can result in high statin blood levels with associated risk of rhabdomyolysis; also true of Erythromycin but not Azithromycin (Ann Int Med 158:869, 2013).",
    "Clarithromycin blocks metabolism of calcium channel blockers; can result in hypotension and renal injury (JAMA 310: 2544, 2013).",
    "Concomitant Clarithromycin and colchicine (for gout) can result in fatal colchicine toxicity due to pancytopenia (Clin Infect Dis 41:291, 2005).",
    "FDA Drug safety communication. Results of 10 year follow-up of trial of 4373 patients with stable coronary heart disease. (Int J Cardiol 182: 459, 2015). For 2 weeks, half received placebo and half received clarithro 500 mg/day. Result: 10% increased risk of death from any cause and a 19% increased risk of cerebrovascular disease. Increased risk mainly in patients not taking a statin and during the first 3 yrs. Observational. Mechanism, if any, is unclear.",
    "See Macrolides, Overview for class-wide adverse effects, including potential EKG QTc interval prolongation."
  ],
  "pregnancy_risk": {
    "fda_risk_category": "Safety data conflict. Macrolide exposure associated with ↑ risk of spontaneous abortion (1st TM use) and ↑ risk of major birth defects in some studies. Use with caution. 8",
    "lactation": "Safe, monitor infant for GI toxicity",
    "footnote": "Capital letter = Old FDA risk category; Text = New FDA risk category. 8: Ref: Pharmacotherapy 2025;45:227"
  },
  "antimicrobial_spectrum": {
    "preferred": [
        "Arcanobacterium sp.",
        "Bartonella hensalae, B. quintana",
        "Bordetella pertussis",
        "Legionella sp."
    ],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": "24-hr AUC/MIC",
    "preparations": "Tab (250, 500 mg), Extended-release tab (500 mg), Oral susp (125 mg/5 mL, 250 mg/5 mL)",
    "food_recommendation": "Tab/susp ± food, ER tab + food",
    "oral_absorption_percent": "50",
    "tmax_hr": "Tab 2.0-2.5, ER tab 5-8",
    "peak_serum_conc_ug_ml": "3-4 (500 mg po q12h, SS), 2-3 (1 gm ER po q24h, SS)",
    "peak_urine_conc_ug_ml": "No data",
    "protein_binding_percent": "65-70",
    "volume_of_distribution_vd_l_kg": "4 L/kg",
    "avg_serum_half_life_hr": "5-7",
    "elimination": "Metabolized (active metab), renal",
    "bile_penetration_percent": "7000",
    "csf_blood_percent": "No data",
    "therapeutic_levels_in_csf": "No data",
    "auc_ug_hr_ml": "20 (500 mg po q12h, 0-24 hr)"
  },
  "enzyme_transporter_mediated_interactions": {
      "cyp450s_substrate": ["CYP3A4"],
      "transporters_substrate": [],
      "ugts_substrate": [],
      "cyp450s_inhibited": ["CYP3A4"],
      "transporters_inhibited": ["PGP", "OATP1B1"],
      "ugts_inhibited": [],
      "cyp450s_induced": [],
      "transporters_induced": [],
      "ugts_induced": [],
      "impact_on_serum_drug_concentrations": "↑"
  },
  "major_drug_interactions": [
      {"drug": "Alfentanil", "effect": "↑ alfentanil"},
      {"drug": "Alprazolam", "effect": "↑ alprazolam"},
      {"drug": "Amiodarone", "effect": "↑ amiodarone"},
      {"drug": "Amlodipine", "effect": "↑ amlodipine"},
      {"drug": "Atazanavir", "effect": "↑ clarithromycin, ↑ atazanavir"},
      {"drug": "Atorvastatin", "effect": "↑ atorvastatin"},
      {"drug": "Bromocriptine", "effect": "↑ bromocriptine"},
      {"drug": "Carbamazepine", "effect": "↑ carbamazepine"},
      {"drug": "Cilostazol", "effect": "↑ cilostazol"},
      {"drug": "Colchicine", "effect": "↑ colchicine", "management": "Adjust"},
      {"drug": "Cyclosporine", "effect": "↑ cyclosporine"},
      {"drug": "Digoxin", "effect": "↑ digoxin"},
      {"drug": "Dihydroartemisinin-piperaquine", "effect": "↑ PPQ"},
      {"drug": "Diltiazem", "effect": "↑ diltiazem"},
      {"drug": "Disopyramide", "effect": "↑ disopyramide"},
      {"drug": "Dofetilide", "effect": "↑ dofetilide"},
      {"drug": "Efavirenz", "effect": "↓ clarithromycin, ↑ 14-OH clarithromycin"},
      {"drug": "Eplerenone", "effect": "↑ eplerenone"},
      {"drug": "Ergot alkaloids", "effect": "↑ ergot alkaloid"},
      {"drug": "Etravirine", "effect": "↓ clarithromycin"},
      {"drug": "Fexinidazole", "effect": "↓ M1, M2 (fexinidazole) metabolites"},
      {"drug": "Itraconazole", "effect": "↑ clarithromycin, ↑ itraconazole"},
      {"drug": "Lovastatin", "effect": "↑ lovastatin"},
      {"drug": "Maraviroc", "effect": "↑ maraviroc"},
      {"drug": "Methylprednisolone", "effect": "↑ methylprednisolone"},
      {"drug": "Midazolam", "effect": "↑ midazolam"},
      {"drug": "Nateglinide", "effect": "↑ nateglinide"},
      {"drug": "Nevirapine", "effect": "↓ clarithromycin, ↑ 14-OH clarithromycin"},
      {"drug": "Nifedipine", "effect": "↑ nifedipine"},
      {"drug": "Nirmatrelvir/RTV", "effect": "↑ clarithromycin"},
      {"drug": "Phenobarbital", "effect": "↓ clarithromycin"},
      {"drug": "Pioglitazone", "effect": "↑ pioglitazone"},
      {"drug": "Pimozide", "effect": "↑ pimozide"},
      {"drug": "Pravastatin", "effect": "↑ pravastatin"},
      {"drug": "Quetiapine", "effect": "↑ quetiapine"},
      {"drug": "Quinidine", "effect": "↑ quinidine"},
      {"drug": "Repaglinide", "effect": "↑ repaglinide"},
      {"drug": "Rifabutin", "effect": "↓ clarithromycin, ↑ rifabutin"},
      {"drug": "Rifampin", "effect": "↓ clarithromycin, ↑ 14-OH clarithromycin"},
      {"drug": "Rifapentine", "effect": "↓ clarithromycin, ↑ 14-OH clarithromycin"},
      {"drug": "Rosiglitazone", "effect": "↑ rosiglitazone"},
      {"drug": "Sildenafil", "effect": "↑ sildenafil"},
      {"drug": "Simvastatin", "effect": "↑ simvastatin"},
      {"drug": "St John's wort", "effect": "↓ clarithromycin"},
      {"drug": "Tacrolimus", "effect": "↑ tacrolimus"},
      {"drug": "Tadalafil", "effect": "↑ tadalafil"},
      {"drug": "Theophylline", "effect": "↑ theophylline"},
      {"drug": "Tolterodine", "effect": "↑ tolterodine (if CYP2D6 deficient)"},
      {"drug": "Triazolam", "effect": "↑ triazolam"},
      {"drug": "Vardenafil", "effect": "↑ vardenafil"},
      {"drug": "Verapamil", "effect": "↑ verapamil"},
      {"drug": "Vinca alkaloids", "effect": "↑ vinca alkaloid"},
      {"drug": "Voriconazole", "effect": "↑ voriconazole (Front Pharmacol 2023;14:1134803)"},
      {"drug": "Warfarin", "effect": "↑ warfarin"},
      {"drug": "Zidovudine", "effect": "↓ zidovudine", "management": "Ser"},
      {"drug": "Zolpidem", "effect": "↑ zolpidem", "management": "(A"}
  ]
}
